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INTRODUCTION
The GABA A receptor is the principal target of propofol and several other sedative and anxiolytic agents (Ferguson et al., 2007; Jurd et al., 2003; Low et al., 2000; Rudolph et al., 1999) . Propofol directly activates the GABA A receptor and can potentiate currents elicited by a low concentration of the transmitter GABA (Hales and Lambert, 1991; Sanna et al., 1995) .
Under physiological conditions, this leads to hyperpolarization of cell or dampening of the effect of excitatory input.
Despite years of research, the location of the site(s) mediating the actions of propofol is unknown. A recent modeling study of the β 3 homomeric receptor identified a hydrophobic cavity near the extracellular end of the membraneous region, predicted to bind propofol with a submicromolar equilibrium dissociation constant (Franks, 2015; Miller and Aricescu, 2014) . The cavity lies in the center of a column triangle formed by the M1 and M2 membrane-spanning domains of the subunit contributing the "-" side of the interface (Chain A in Figure 1 ) and the M2 domain of the neighboring subunit that contributes the "+" side of the interface (Chain B in Figure 1 ). Molecular docking places the propofol molecule at the "-" side next to the β 3(H267) residue (Franks, 2015) . Incidentally, this residue is photolabeled by the photoreactive propofol analog, ortho-propofol diazirine (Yip et al., 2013) . The key residue at the "+" side of the interface is T266 that points into the cleft towards the phenol ring of propofol. The cleft is capped from the extracellular side by the Y143 and F221 residues at the boundary between the extracellular and membrane-spanning domains (Franks, 2015) .
Mutations to this region affect receptor properties. The interface, whose involvement in the actions of propofol has been suggested by previous photolabeling and functional studies (Bali and Akabas, 2004; Jayakar et al., 2014; Krasowski et al., 2001a) . It is therefore plausible that contribution from the unaltered β -α interfaces conceals the true effect exerted by the H267A mutation at the "-" side of the β subunit. The second caveat is that the experiments were conducted using the photolabeling reagent ortho-propofol diazirine.
It remained unclear whether the mutations influence activation by the parent compound, propofol.
Mutational studies in general can be ambiguous with regard to the underlying mechanism of effect. Changes in activation properties may result from the mutation interfering with the binding of ligand or signal transduction, with the distinction between the two not always being straightforward (Colquhoun, 1998) . Photolabeling studies may present a more direct approach to identify the regions involved, however, a mutational study can reveal the functional involvement of a site.
To gain further insight into the role of the cavity formed by the M1 and M2 membranespanning domains at the intersubunit interface, we tested the effects of mutations to selected residues in This article has not been copyedited and formatted. The final version may differ from this version. 
MATERIALS AND METHODS
The experiments were conducted on wild-type and mutant human (Franks, 2015) using a relatively low-resolution (3Å) crystal structure (Miller and Aricescu, 2014) , this was quite sufficient to highlight which residues might contribute to a possible propofol binding site.
All mutations were made using the QuikChange site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA). The β 3 subunit contained the FLAG epitope in the amino terminus of the subunit (Ueno et al., 1996) . The clones were fully sequenced prior to use. All mutated receptors, with the exception of β 3(T263W) homomers, were functional.
The cDNAs, subcloned into the pcDNA3 vector, were linearized by digestion with Xba I (β3; NEB Labs, Ipswich, MA) or Bgl II (α1; Roche Diagnostics, Indianapolis, IN). The cRNAs were produced using mMessage mMachine (Ambion, Austin, TX). The oocytes were injected with a total of 3-18 ng cRNA in a final volume of 20-40 nl, and incubated in ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 2.5 mM Na pyruvate, 5 mM HEPES; pH 7.4) at 16 o C. The
This article has not been copyedited and formatted. The final version may differ from this version. The level of spontaneous activity was determined by comparing the effect of 10-100 µM picrotoxin to the response to saturating pentobarbital which, in all cases where β 3 homomeric configuration was employed, produced a larger current response than saturating propofol.
Spontaneous activity, expressed in units of estimated open probability (P o est ), was calculated assuming that P o was 0 in the presence of saturating picrotoxin and 1 in the presence of saturating pentobarbital. This approach is similar to the one described previously for heteromeric GABA A receptors (Eaton et al., 2014; Forman and Stewart, 2012) . We note,
however, that this approach may result in overestimation of P o,spont , because the actual P o in the presence of saturating pentobarbital may be less than 1. In some cases (e.g.,
saturating pentobarbital was more effective at blocking spontaneous activity than 100 µM picrotoxin. For those receptors, P o,spont est was calculated assuming that the P o reached 0 during the initial blocking action of pentobarbital and 1 during the rebound response following termination of pentobarbital application.
Parameters for binding and gating in the presence of propofol or pentobarbital were derived from fitting the P o est from pooled data to the following equation (Chang and Weiss, 1999; Rusch et al., 2004) :
This article has not been copyedited and formatted. The final version may differ from this version. Table 2 .
Potentiation of α 1β3 receptors was estimated by examining the effect of a low concentration of propofol on currents elicited by a low concentration of GABA. Test GABA concentration was selected to produce a response of approximately 5% of the maximal response to GABA.
Propofol was used at a concentration that elicited a response of less than 3% of the maximal response to GABA. The potentiating effect of propofol was calculated as I (GABA+propofol) / (I GABA + I propofol ). Statistical analysis was conducted by comparing the potentiating effect to 1 (i.e., no effect), using a two-tailed paired t-test (Excel). This test, equivalent to a one-sample t-test with a MOL #100347
1 2 Table 2 ). We infer based on these data that the histidine sidechain in position 267 does not contribute significantly to activation properties of β 3 homomeric GABA A receptors.
RESULTS
Activation of wild-type and mutant human
We conducted further mutational analysis of selected residues in the putative propofol binding pocket. The Franks (Franks, 2015) proposed that the main chain carbonyl oxygen of residue
forms a hydrogen bond with the oxygen atom of propofol. While we were unable to make modifications to the peptide bond, we reasoned that addition of bulk to the sidechain at this position may interfere with optimal positioning of the propofol molecule in the cavity and affect propofol activation properties. Receptors containing the was without effect (7 cells) whereas application of 500 µM propofol elicited an apparent outward current (3 cells), indicative of block of spontaneous activity. Exposure to 10-100 µM picrotoxin also resulted in apparent outward current. Application of 3 mM pentobarbital resulted in an initial outward current that we interpret as block of spontaneous activity, followed by an inward rebound current upon the removal of the drug, that extended beyond the baseline level (a total of 22 cells). Incidentally, pentobarbital, at 3 mM, was a more efficacious blocker than 100 µM picrotoxin or 500 µM propofol. These findings indicate that the β 3(F221W) mutant produces a high level of spontaneous activity. Using the current level during the application of 3 mM pentobarbital for P o est of 0 and the rebound current level in the end of pentobarbital application for P o est of 1, we estimate that P o,spont est equals 0.62 ± 0.04 (22 cells). The concentrationresponse relationship for pentobarbital was rightshifted in the mutant and had an EC 50 of 523 ± 45 µM (9 cells).
The propofol activation curve in β 3(Y143W) had an EC 50 of 22 ± 6 µM (5 cells; p < 0.05 vs.
wild-type). The concentration-response relationship for pentobarbital was not affected by the mutation, and had an EC 50 of 82 ± 24 µM (5 cells). We estimate that the P o,spont est for
is 0.21 ± 0.02 (4 cells), which is a moderate increase (p < 0.05) over P o,spont est in wild-type. By
This article has not been copyedited and formatted. The final version may differ from this version. We also tested the effect of placing a tryptophan residue in place of β 3(T266). This residue is pointed towards the putative propofol-binding cavity, however, it is supplied by the neighboring subunit that contributes the "+" side to the intersubunit interface (Figure 1 ). The β 3(T266W) receptor showed minimal activation by propofol. In the presence of 10 µM propofol, the peak response was 4 ± 1% (7 cells) of the response to 3 mM pentobarbital. Exposure to higher concentrations of propofol resulted in outward current that we interpret as block of spontaneous activity. The concentration-response relationship for pentobarbital was shifted to higher agonist concentrations (EC 50 = 389 ± 81 µM; 4 cells). By comparing block by 100 µM picrotoxin to the rebound response upon termination of the application of saturating (3 mM) pentobarbital we estimate that the open probability of spontaneous activity is 0.34 ± 0.08 (5 cells) in β 3(T266W).
Activation of wild-type and mutant β 3 receptors by propofol analogs
To gain insight into the mechanism by which tryptophan substitutions reduce activation by propofol, we examined the effects of mutations on activation by propofol analogs with different ortho substituents. The experiments were conducted by comparing responses to a saturating concentration of pentobarbital (300 µM in β 3 wild-type, 3 mM in mutants) and, typically, 500 µM propofol analog in the same cell. In some cases (e.g., 2-tert-butyl-6-methylphenol on F221W or T266W), only blockade of spontaneous activity was observed at 500 µM, so a lower concentration (10 µM) was employed to compare peak responses.
The data suggest that the deleterious effect of the ) for 2-isopropylphenol, 2,6-dimethylphenol, 2,6-diethylphenol, and 2-tert-butyl-6-methylphenol, respectively. When the receptor contained the β 3(T266W) mutation, the response ratios were 0.12 ± 0.03 (5 cells), 0.13 ± 0.04 (6 cells), 0.12 ± 0.02 (5 cells), and 0.06 ± 0.02 (4 cells) for 2-isopropylphenol, 2,6-dimethylphenol, 2,6-diethylphenol, and 2-tert-butyl-6-methylphenol, respectively. We propose that these residues are involved in signal transduction or located near an unaltered part of the propofol molecule (e.g., the hydroxyl group). The data are summarized in Figure 4 . Figure 5 and Table 3 .
We also conducted a test on receptor potentiation by propofol. For that, GABA at a concentration producing an EC 5 response was applied in the absence and presence of a low concentration of propofol (see Methods for details). Proper comparison of potentiation across mutants may be complicated by differences in maximal open probability for GABA, so we used this experiment as a simple qualitative test of whether potentiation is present or absent in the particular receptor.
As expected, wild-type As a negative control, we examined the properties of the α 1β3(T266W) receptor. As expected, this mutation had a relatively small effect on activation and potentiation properties.
The midpoint of the propofol concentration-response curve was left-shifted to 4.0 ± 0.5 µM (5 cells; p < 0.01). In the presence of pentobarbital, there was a trend in EC 50 to higher concentrations (EC 50 = 166 ± 42 µM, 5 cells), but the effect did not reach statistical significance.
The EC 50 for GABA was left-shifted to 0.2 ± 0.04 µM (4 cells). Receptors activated by low GABA (EC 5 ) were potentiated by 3.5 ± 0.2 fold (5 cells) in the presence of 1 µM propofol.
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DISCUSSION
A recent modeling study postulated a high-affinity propofol binding site at the intersubunit interface in β 3 homomeric GABA A receptors (Franks, 2015) . The putative binding site lies in the middle of a triangular structure formed by the M1 and M2 membrane-spanning domains of a subunit contributing the "-" side of the interface and the M2 domain of the neighboring subunit that contributes the "+" side of the interface (Figure 1 ). The goal of the present study was to investigate the role of selected residues lining this cavity, using electrophysiology to gain functional evidence for its role in activation by propofol. We introduced tryptophan residues to Y143, F221, Q224, and H267 at the "-" side and T266 (in the β 3 subunit) or I271 (α1 subunit) at the "+" side of the intersubunit interface. The major experimental finding is that mutations at some of these locations strongly reduce or eliminate activation by propofol with less significant effect on activation by pentobarbital.
We began this study with the null hypothesis that the cavity around the β 3(H267) residue is not involved in activation of the β 3 homomeric GABA A receptor by propofol. We reasoned that while a functional effect of a mutation is supportive of involvement but ultimately inconclusive, lack of selective functional effect is an indication that a residue is not a critical component of the interaction site. We chose to make tryptophan substitutions. Tryptophan, due to its added bulkiness, is more likely to exclude the ligand, or, perhaps, mimic its presence in the binding properties. Specifically, there was no increase in spontaneous activity or shift in propofol EC 50 .
Comparison of maximal currents in the presence of propofol and pentobarbital in β 3(H267W)
suggests a nearly 2-fold reduction in gating efficacy by propofol, but the caveat is that the difference may be caused by a change in P o for pentobarbital rather than propofol. In the case of heteromeric GABA A receptors, the estimate for maximal P o can be obtained by examining the ability of various potentiators to enhance the response to saturating agonist (e.g., (Eaton et al., 2014; Forman and Stewart, 2012) ). We were, however, unable to observe potentiation of This article has not been copyedited and formatted. The final version may differ from this version. generated with the overall mean EC 50 values from Table 1 . In A, the maximal fitted response and n H were 1.05 ± 0.03 and 1.6 ± 0.2 (wild-type), 1.07 ± 0.02 and 1.7 ± 0.1 (H267W), 1.1 ± 0 and 1.6 ± 0.1 (L268W), and 0.99 ± 0.04 and 0.98 ± 0.16 (Y143W). Receptors containing the T266W, Q224W, or F221W mutations did not reliably produce responses in the presence of propofol. In B, the maximal fitted response and n H were 1.03 ± 0.03 and 1.6 ± 0.04 (wild-type),
This article has not been copyedited and formatted. The final version may differ from this version. 1.14 ± 0.03 and 1.8 ± 0.3 (H267W), 1.0 ± 0.03 and 1.8 ± 0.2 (L268W), 1.05 ± 0.04 and 1.1 ± 0.04 (Y143W), 1.03 ± 0.03 and 0.9 ± 0.2 (T266W), and 0.98 ± 0.02 and 2.9 ± 0.04 (Q224W). spanning from P o of 0 to P o of 1. The curves were generated by fitting Eq. 2 (with n = 4 sites) to the P o data. Fitting parameters are given in Table 3 . µM (wild-type) or 3 mM (mutants). A value of 1 for the calculated parameter means that the compound/pentobarbital current ratio is the same in the mutant and wild-type. The actual compound/pentobarbital current ratios for wild-type and mutant receptors are provided in the text. Statistical analysis (t-test, Excel, Microsoft) was conducted by comparing the calculated parameter value to 1. The data show that the β 3(Y143W) mutation does not affect the current ratio for 2-isopropylphenol or 2,6-dimethylphenol while the β 3(Q224W) mutation does not affect the current ratio for 2-isopropylphenol or 2-tert-butyl-6-methylphenol. Table 3 . In cases where no clear saturation was observed but higher drug concentrations produced block, Y max was constrained to the value of the highest current response. In A, the maximal fitted response and n H were 1.07 ± 0.01 and 1.7 ± 0.3 (α1β3), 1.0 (constrained) and 4.3 ± 0.7 (α1β3(T266W)), 1 and 2.0 ± 0.1 (α1(I271W)β3), and 0.98 ± 0.02 and 2.9 ± 0.4 (α1(I271W)β3(T266W)). In B, the maximal fitted response and n H were 1 and 2.1 ± 0.3 (α1β3), 1.07 ± 0.03 and 0.9 ± 0.06 (α1β3(T266W)), 1.02 ± 0.01 and 2.4 ± 0.1 (α1(I271W)β3), and 1 and 2.9 ± 0.6 (α1(I271W)β3(T266W)). In C, the maximal fitted response and n H were 1.04 ± 0.01 and 1.5 ± 0.1 (α1β3), 1.07 ± 0.06 and 0.8 ± 0.1 (α1β3(T266W)), 1.0 and 2.0 ± 0.1 (α1(I271W)β3), and 1.04 ± 0.03 and 1.3 ± 0.2 (α1(I271W)β3(T266W)).
